See also this year's filing and all EDGAR filings for this company.
PDF Report 0000316253_2015_ENZO_Biochem_INC.pdf
Logs
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.008121497604158206, 'aggregate_val': 24826000, 'exp_sum': 24626000, 'exp_to_value': {'LongTermLiabilities': 774000, 'LiabilitiesCurrent': 23852000, 'remainder_Liabilities': 0}} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.006708702984089742, 'aggregate_val': 27461000, 'exp_sum': 27278000, 'exp_to_value': {'LongTermLiabilities': 2313000, 'LiabilitiesCurrent': 24965000, 'remainder_Liabilities': 0}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000316253, ENZO Biochem INC
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 15,560,000 |
1 | AssetsNonCurrent | 385,000 |
2 | AssetsCurrent | 40,736,000 |
3 | PropertyPlantAndEquipment | 7,730,000 |
4 | remainder_Assets | 0 |
5 | LongTermLiabilities | 2,313,000 |
6 | LiabilitiesCurrent | 24,965,000 |
7 | remainder_Liabilities | 183,000 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 41,801,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 0 |
13 | DepreciationDepletionAndAmortization | 0 |
14 | SellingAndMarketingExpense | 0 |
15 | ResearchAndDevelopmentExpense | 3,141,000 |
16 | remainder_Expenses | 61,257,000 |
17 | remainder_Revenues | 95,947,000 |
18 | remainder_NetIncome | 275,000 |
19 | remainder_ComprehensiveNetIncome | -114,000 |
yvar | yval | |
---|---|---|
0 | Assets | 64,411,000 |
1 | Liabilities | 27,461,000 |
2 | Expenses | 106,199,000 |
3 | Revenues | 95,947,000 |
4 | StockholdersEquity | 36,950,000 |
5 | NetIncome | -9,977,000 |
6 | ComprehensiveNetIncome | -10,091,000 |
7 | BaseVar | 147,203,500 |
8 | EconomicCapitalRatio | 2.02 |